Meet XCOR, One Of The Little Guys In The Commercial Spaceflight Race

Related Posts

10Nov

eSight Certified as a Great Place to Work® for Second Year in a Row

Leading vision-enhancement platform, eSight, today announces it has once again been certified as a Great Place to Work® after a... read more
12Dec

Nudge Money Announces Partnership with Candidly to Empower Users to Tackle Student Debt

Nudge Money, the preeminent full-spectrum AI Financial Wellness Solution, announced today a partnership with Candidly, the leading AI-driven student debt... read more
14Apr

Meet the FinTech Breakthrough Award Winners

2022 Winners - Personal Finance - Future Fuel, Best Personal Finance Platform. Read more >> read more
14Apr

Pyramid Biosciences Expands Oncology Pipeline with In-Licensing of GQ1010, a Potential Best-in-class TROP2 Targeted Antibody Drug Conjugate (ADC), from GeneQuantum Healthcare

Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing transformative medicines for patients with cancer, today announced that... read more
02Dec

Pyramid Biosciences’ $864 Million Licensing Deal

Clinical-stage biotechnology company Pyramid Biosciences, Inc. announced the development of a global licensing deal for two cancer therapies worth up... read more
24Feb

Embrace the boom at Silver Economy Summit

On March 6 and 7, the Department of Seniors and the Halifax Chamber of Commerce are presenting the fourth Annual... read more
17Sep

Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease

Xylyx Bio, Inc., a regenerative medicine company developing pioneering solutions for tissue and organ modeling and repair, announced today that... read more
10May

Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents... read more
14Sep

AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc.... read more
11Sep

Rapid Lyme test developed at Cornell could be ‘major breakthrough’ in treatment

The test would quickly confirm the presence of the bacteria that causes Lyme, rather than waiting for weeks for a... read more